Contact Us
Advanced Imaging for Glaucoma
Doheny Eye Institute, USC
1450 San Pablo Street, Room 4601
Los Angeles, CA 90033
(866) 450-6782
info@aigstudy.net
|
Welcome to the AIG Study Website
Advanced Imaging for Glaucoma (AIG) is a multi-center bioengineering partnership sponsored by the National Eye Institute, one of the National Institutes of Health (NIH).
The goal of this partnership is to develop advanced imaging technologies that can improve the detection and management of glaucoma. Currently-employed advanced imaging devices include optical coherence tomography, scanning laser polarimetry and scanning laser tomography. The imaging technologies will be evaluated in a longitudinal 5-year clinical trial. The study subjects will include patients with normal eyes, patients with glaucoma, and individuals at risk for developing glaucoma.
Organization
The coordinating center for the AIG partnership is located at the University of Southern California (USC). There are a total of four centers that will be conducting the AIG clinical study, and four basic science and engineering centers that will develop the advanced imaging instruments and conduct laboratory studies on glaucoma.
The three clinical centers are:
 | University of Miami, Bascom Palmer Eye Institute, Miami, Florida;
| | University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and
| | University of Southern California, Doheny Eye Institute, Los Angeles, California. |
The three basic science and engineering centers are:
| Case University, Cleveland, Ohio;
| | University of Miami, Bascom Palmer Eye Institute, Miami, Florida; and
| | University of Southern California, Doheny Eye Institute, Los Angeles, California. |
Specific Aims
The specific aims of the AIG clinical studies are to:
1. Predict the development of visual field (VF) abnormalities in individuals at risk for developing glaucoma based on anatomic abnormalities detected by advanced imaging;
2. Predict the development of VF abnormalities in individuals at risk for developing glaucoma based on anatomic changes detected between successive advanced imaging tests; and
3. Determine the sensitivity and specificity of a glaucoma diagnosis based on advanced imaging tests.
| 
